BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 9041690)

  • 1. Gastric MALT lymphoma and Helicobacter pylori.
    Wotherspoon AC
    Yale J Biol Med; 1996; 69(1):61-8. PubMed ID: 9041690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
    Begum S; Sano T; Endo H; Kawamata H; Urakami Y
    J Med Invest; 2000 Feb; 47(1-2):36-46. PubMed ID: 10740978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric MALT lymphoma and Helicobacter pylori.
    Spencer J; Wotherspoon AC
    Cancer Surv; 1997; 30():213-31. PubMed ID: 9547994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-dependent progression of mucosa-associated lymphoid tissue (MALT)-type lymphoma in the stomach. Effects of antimicrobial therapy on gastric MALT lymphoma in mice.
    Enno A; O'Rourke J; Braye S; Howlett R; Lee A
    Am J Pathol; 1998 Jun; 152(6):1625-32. PubMed ID: 9626066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary gastric lymphoma.
    Isaacson PG
    Br J Biomed Sci; 1995 Dec; 52(4):291-6. PubMed ID: 8555783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue.
    Hussell T; Isaacson PG; Crabtree JE; Spencer J
    J Pathol; 1996 Feb; 178(2):122-7. PubMed ID: 8683376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
    Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
    J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of lymphocyte homing receptors and vascular addressins in low-grade gastric B-cell lymphomas of mucosa-associated lymphoid tissue.
    Dogan A; Du M; Koulis A; Briskin MJ; Isaacson PG
    Am J Pathol; 1997 Nov; 151(5):1361-9. PubMed ID: 9358762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of primary gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma after eradication of Helicobacter pylori.
    Falcó Jover G; Martínez Egea A; Sánchez Cuenca J; Onrubia Pintado J; García Lafuente N; Ruiz Gómez F; Coronas Planas M
    Rev Esp Enferm Dig; 1999 Aug; 91(8):541-8. PubMed ID: 10491486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric lymphoma and Helicobacter pylori.
    Isaacson PG; Spencer J
    Important Adv Oncol; 1996; ():111-21. PubMed ID: 8791131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type.
    Delchier JC; Lamarque D; Levy M; Tkoub EM; Copie-Bergman C; Deforges L; Chaumette MT; Haioun C
    Am J Gastroenterol; 2001 Aug; 96(8):2324-8. PubMed ID: 11513169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric lymphoma of mucosa-associated lymphoid tissue and Helicobacter pylori.
    Wotherspoon AC
    Annu Rev Med; 1998; 49():289-99. PubMed ID: 9509264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of CXCR3 expression in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type for predicting responsiveness to Helicobacter pylori eradication.
    Yamamoto H; Nakamura T; Matsuo K; Tajika M; Kawai H; Ohmiya N; Niwa Y; Goto H; Nakamura S
    Cancer Sci; 2008 Sep; 99(9):1769-73. PubMed ID: 18616679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
    Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
    Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological and molecular analysis of B lymphocytes in low-grade MALT lymphoma of the stomach. Are there any useful markers for predicting outcome after Helicobacter pylori eradication?
    Matsushima Y; Kinoshita Y; Fukui H; Maekawa T; Yazumi S; Okada A; Nakase H; Kawanami C; Iwano M; Hashimoto K; Takeda Z; Okazaki K; Chiba T
    J Gastroenterol; 2002; 37(6):428-33. PubMed ID: 12108676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primary non-Hodgkin lymphoma of the stomach. A review with special reference to the MALT concept].
    Cogliatti SB; Schmid U
    Schweiz Med Wochenschr; 1994 Oct; 124(40):1764-74. PubMed ID: 7939542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric low-grade B-cell MALT lymphoma: treatment, response, and genetic alteration.
    Nakamura T; Inagaki H; Seto M; Nakamura S
    J Gastroenterol; 2003; 38(10):921-9. PubMed ID: 14614598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
    Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
    Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid development of diffuse large B-Cell lymphoma after successful eradication of Helicobacter pylori for gastric MALT lymphoma.
    Iwano M; Watanabe N; Matsushima Y; Seno H; Oki K; Sakurai T; Inagaki H; Okazaki K; Chiba T
    Am J Gastroenterol; 2006 Dec; 101(12):2878-83. PubMed ID: 17026570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of low-grade gastric MALT lymphoma with Helicobacter pylori eradication. Follow-up of the histological and molecular response].
    Montalbán C; Manzanal A; Boixeda D; Redondo C; Alvarez I; Frutos B; Calleja JL; Sánchez-Godoy P; Bellas C
    Med Clin (Barc); 1998 Jan; 110(2):41-4. PubMed ID: 9534129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.